P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold.
Bioorg Med Chem Lett
; 15(11): 2771-5, 2005 Jun 02.
Article
em En
| MEDLINE
| ID: mdl-15911253
ABSTRACT
In this study, we have demonstrated that the critical hydrogen bonding motif of the established 3-aminopyrazinone thrombin inhibitors can be effectively mimicked by a 2-aminopyridine N-oxide. As this peptidomimetic core is more resistant toward oxidative metabolism, it also overcomes the metabolic liability associated with the pyrazinones. An optimization study of the P(1) benzylamide delivered the potent thrombin inhibitor 21 (K(i) = 3.2 nM, 2xaPTT = 360 nM), which exhibited good plasma levels and half-life after oral dosing in the dog (C(max) = 2.6 microM, t(1/2) = 4.5 h).
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Pirimidinas
/
Antitrombinas
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article